Finnish Clinical Biobank Tampere (FCBT) was established by Pirkanmaa Hospital District, University of Tampere, Etelä-Pohjanmaa Hospital District and Kanta-Häme Hospital District. FCBT’s role is to support disease prevention, studies on the effectiveness or side effects of treatment of patients, and studies exploiting pathological findings. The main focus of the biobank, in accordance with the research strategy defined by the University of Tampere and Pirkanmaa Hospital District, is research in cardiovascular disease, cancer, immunology and type 1 diabetes. FCBT’s license to operate was granted by the National Supervisory Authority for Welfare and Health, Valvira, on September 8th, 2015.
The aim is to start sample collection gradually during 2016.
Tel. +358-50-590 7515
E-mail: email@example.com, biopankki(a)tays.fi